From Hope to Silence: The Hidden Stories of 128,127 Patients in Discontinued and Unpublished Obesity Trials
Year: 2025
Type: article
Abstract: The growing and ongoing obsession for treating obesity has led to the use of diabetic treatment injections to try and cure this disease. Anti-diabetic drugs (e.g., Liraglutide/Saxenda, Ozempic, Metformin and Mounjaro) have shown promising weight-loss results in clinical settings. Our study analyzes the discontinuation and non-publication of clinical trials concerning the use of diabetes injections (GLP-1 Agonists) in treating obesity.
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4414916627
FWCI:
Cites:
Cited by:
Related to: